INVESTOR DAY Annual Meeting of Shareholders

Similar documents
Investor Presentation

Second Quarter 2017 Financial Results Conference Call August 10, 2017

INVESTOR DAY 4. Second Quarter Financial Results Conference Call

Fourth Quarter 2013 Financial Results Conference Call & Webcast April 1, 2014

First Quarter 2014 Financial Results Conference Call & Webcast May 7, 2014

Corporate Presentation First Quarter 2010

Canaccord Capital Inc. to acquire Adams Harkness Financial Group, Inc. Expanding global small to mid cap market niche into the United States

ALBERTA FORECAST HOW LONG WILL IT LAST?

Canadian Western Bank Group. Third Quarter 2011 Corporate Presentation

McKesson Corporation J.P. Morgan Healthcare Conference

Corporate Presentation

Corporate Presentation. 3rd Quarter 2016

Corporate Presentation Third Quarter 2010

Canadian Western Bank Group

48 HOURS IN EDMONTON. October 2014

Canadian Western Bank Group

FY 2015 Results Presentation. 19 January 2016

INVESTOR PRESENTATION

Investor Presentation September 2018

36th Annual J.P. Morgan Healthcare Conference

Forward looking statements

June Investor Presentation

Artis Real Estate Investment Trust

INVESTOR PRESENTATION

Investor Presentation August 23, 2017

Hill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016

Provincial and National Employment, Alberta and Canada Employment Rates 1, % 62.7% 62.7% 63.0% 63.5%

Fiscal Year 2011 Core Strategies and Milestones Express Scripts Update

Click to edit Master title style. Growth through sustainable cash flow

Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014

TSX:LEAF Investor Presentation October 2017

Investor Presentation November 2018

Acquisition of Northpoint Commercial Finance A Leading North American Inventory Finance Lender. May 18, 2017

Investor Update MARCH 2018

2009 UBS Healthcare Services Conference


Saskatchewan Labour Force Statistics

Investor Presentation. August 2007

Morgan Stanley Australian Emerging Companies Conference

Optimized. Enhanced. INVESTOR PRESENTATION NOVEMBER 2017 TSX: DR

Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier

TSX:LEAF Investor Presentation December 2017 Top Licensed Producer

Investor Presentation. February 2012

TSX:LEAF Investor Presentation March 2018

Investor Presentation. April 2011

2011 Financial report


Acquisition of Fishers

MMM acquisition and related financing

INVESTOR PRESENTATION

Click to edit Master title style. Growth through sustainable cash flow

Management s Discussion & Analysis

PLANNING FOR SUSTAINABILITY:

Baird 2018 Global Healthcare Conference. September 5, 2018

Our online services Less paper. More efficient. GROUP INSURANCE

Cowen and Company 37 th Annual Health Care Conference. March 6, 2017

Postmedia Network Canada Corp. Q1 F2016 Investor and Analyst Conference Call January 13, 2016

MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

UNIQUELY POSITIONED FOR THE FUTURE

JP Morgan Healthcare Conference January 13, 2016

Click to edit Master title style. Growth through sustainable cash flow

INVESTOR PRESENTATION

Management s Discussion & Analysis

Cowen and Company 38 th Annual Health Care Conference. March 13, 2018

Creating Value by Accelerating Transformation & Growth

LIQUOR STORES INCOME FUND

35th Annual J.P. Morgan Healthcare Conference. January 12, 2017

CSL. CANADIAN STUDENT LIVING GROUP INC. Investor Presentation

For personal use only

Housing Bulletin Monthly Report

LIQUOR STORES INCOME FUND

DH CORPORATION Management s Discussion and Analysis For the quarter ended March 31, 2016

Cara Operations to Merge with Keg Restaurants Ltd. January 23, 2018

BERNSTEIN. 34 th Annual Strategic Decisions Conference. David Wichmann, CEO May 31, 2018

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015

ECOLAB FIRST QUARTER 2018

Press Release Stockholm 2 May 2017 MEDICOVER INTENDS TO LIST ON NASDAQ STOCKHOLM

President s Office Bureau du Président

INVESTOR PRESENTATION MAY 2017

ALEGRO HEALTH CORP. MANAGEMENT S DISCUSSION AND ANALYSIS OF OPERATING RESULTS AND FINANCIAL POSITION

WEB CAST PRESENTATION

I n v e s t o r P r e s e n t a t i o n A c q u i s i t i o n o f C a n n a F a r m s

J.P. Morgan Healthcare Conference

ATLAS ENGINEERED PRODUCTS REPORTS RECORD QUARTERLY AND ANNUAL REVENUES AT YEAR-END FISCAL 2018

Investor Presentation

2016 Census: Release 4. Income. Dr. Doug Norris Senior Vice President and Chief Demographer. September 20, Environics Analytics

for Exceptional Healthcare

Focus on the audit committee Thursday, January 7, 2016

InterRent Real Estate Investment Trust Management s Discussion and Analysis For The Year Ended December 31, 2011

TD Covered Bond (Legislative) Programme Monthly Investor Report Calculation Date: 30-Jun-15

Jefferies 2017 Health Care Conference

Investor presentation

WELCOME 2017 Annual Meeting of Stockholders. May 18, 2017

Visit the new K-BroLinen.com. Annual Report

TD Covered Bond (Legislative) Programme Monthly Investor Report

TD Covered Bond (Legislative) Programme Monthly Investor Report

Artis Real Estate Investment Trust

news FOR IMMEDIATE RELEASE

Labour Market Information Monthly

FOR IMMEDIATE RELEASE. Genesis HealthCare Contact: Investor Relations GENESIS HEALTHCARE REPORTS FIRST QUARTER 2015 RESULTS

Transcription:

INVESTOR DAY 2014 Annual Meeting of Shareholders May 10, 2017

Dr. Jack Shevel Chairman

INVESTOR DAY 2014 Annual Meeting of Shareholders May 10, 2017

David Cutler President & Chief Executive Officer

Forward Looking Statements Certain of the statements contained in this presentation are "forward-looking information within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs, goals, objectives, information and statements about possible future events. Forward-looking information generally can be identified by the use of forward-looking terminology such as outlook, objective, may, will, expect, intend, estimate, anticipate, believe, should, plans or continue, or similar expressions suggesting future outcomes or events. You are cautioned not to place undue reliance on such forward-looking information. Forward-looking information is based on current expectations, estimates and assumptions that involve a number of risks, which could cause actual results to vary and in some instances to differ materially from those anticipated by Centric Health and described in the forward-looking information contained in this presentation. No assurance can be given that any of the events anticipated by the forward-looking information will transpire or occur or, if any of them do so, what benefits Centric Health will derive therefrom and neither Centric Health nor any other person assumes responsibility for the accuracy and completeness of any forward-looking information. Other than as specifically required by applicable laws, Centric Health assumes no obligation and expressly disclaims any obligation to update or alter the forwardlooking information whether as a result of new information, future events or otherwise. All dollar figures are in Canadian dollars unless otherwise stated. 5

Realignment Success 1. 2. 3. 4. Reduced debt by >$230 million Annual interest expense savings >$20 million Improved debt/ebitda and interest coverage ratios Simplified balance sheet Financial flexibility to act on opportunities 6

New Debt Facility $113.5M Facility includes: $100M secured senior facility $13.5M subordinated term credit facility Option to increase the senior facility by additional $25M Cost of debt reduced from $26.4M to <$4.5M Five-year maturity 7

Centric Health Value Proposition Uniquely positioned to complement the Canadian healthcare system during a period of unprecedented challenges. Increasing consumption/utilization driving higher costs Aging population Increasing wait lists/constrained access Demand for better outcomes Large, national networks with significant capacity and operating leverage Reputation for trusted care based on overriding commitment to quality Extensive, trusted relationships with payers and providers Proven intellectual capital + systems = expert solutions and highest level of clinical outcomes Focus on innovation and technology Increasingly favourable payer, provider and patient attitudes toward independently provided healthcare 8

One of the Largest Providers in Canada Doublecheck # s 20 fulfilment centres Vancouver Nanaimo Victoria Kelowna Richmond Calgary Edmonton (3) Lethbridge Medicine Hat Grande Prairie (2) Lacombe # of beds serviced Regina 17,039 19,048 20,377 Newmarket 25,184 Burlington (2) London Ottawa 29,054 >425 long-term care and retirement homes >29,000 beds >1,000,000 prescriptions monthly 2012 2013 2014 2015 2016 9

Specialty Pharmacy: Multiple Growth Opportunities Leverage unique technology and patient service model Key to winning RFPs: 1,200 bed expansion won post Q1 Expand geographic diversity Serve broader patient group Province of Quebec: 16,000 bed opportunity 4 million seniors living at home Innovative technology solution

National Network with Significant Operating Leverage 5 facilities 25 operating rooms 8 procedure rooms 72 beds 245 physicians Toronto facility has one of only three private hospital licenses in Ontario 11

Growth Strategy Drive Utilization 42% 44% 38% 33% 24% 20% 2012 2017 Utilization Rate 1. 2. 3. 4. 5. 6. Grow third-party payer services (insurers, benefits providers, employers) Relationships with physicians & health authorities Accreditations & facilities quality to support preferred provider status Expanded diagnostics offerings Increase outsourcing from governments Coordinate interprovincial & foreign procedures Grow volume of uninsured services Marketing & promotions, including expanded online marketing Add new technologies Develop Centres of Excellence (Bariatrics) Target 50% capacity utilization in medium-term 12

Continued Strong Results Revenue Adj. EBITDA 1 1 (in Millions, C$) (in Millions, C$) 160.8 5% 3 Margin: 8.6% 9.3% 7.1% 10.2% 2 169.1 3 40.7 10.7% 45.1 2 2 13.7 3 13.4% 15.6 55% 4.5 2.9 8.5 2015 2016 Q1 2016 Q1 2017 2015 2016 Q1 2016 Q1 2017 12 consecutive quarters of growth in revenue and adj. EBITDA 13 1. From continuing operations. 2. Normalized for the reclassification of revenue as cost of sales - $1.7 in Q4/16 and $1.5M in Q1/17. 3. Normalized for outsized corporate costs to support since-discontinued operations.

Poised to Generate Shareholder Value Significantly reduced leverage & strengthened balance sheet Compelling Canadian healthcare industry fundamentals create unique macro opportunity Strong margins, strong cash flows, low maintenance capex and working capital needs Leading market positions and national networks with significant operating leverage Strong organic growth potential plus accretive acquisition opportunities Deeply experienced, well aligned management team and strong partnerships with healthcare providers 14

INVESTOR DAY 2014 Annual Meeting of Shareholders May 10, 2017